{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:10:27Z","timestamp":1762431027734,"version":"3.41.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ejca.2015.07.044","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T05:39:20Z","timestamp":1440740360000},"page":"2545-2552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients"],"prefix":"10.1016","volume":"51","clinical-trial-number":[{"clinical-trial-number":"nct00833625","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Elena","family":"Elimova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elba","family":"Etchebehere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Shiozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Shimodaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopma","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatram","family":"Planjery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Charalampakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela A.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Weston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoop S.","family":"Bhutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane E.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipen","family":"Maru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heath D.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homer A.","family":"Macapinlac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaffer A.","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2015.07.044_b0005","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.ejca.2015.07.044_b0010","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2015.07.044_b0015","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.ejca.2015.07.044_b0020","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/jnci\/djn211","article-title":"Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age","volume":"100","author":"Brown","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2015.07.044_b0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence","volume":"97","author":"Pohl","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2015.07.044_b0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/jnci\/djg047","article-title":"Population attributable risks of esophageal and gastric cancers","volume":"95","author":"Engel","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2015.07.044_b0035","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2015.07.044_b0040","doi-asserted-by":"crossref","first-page":"830","DOI":"10.6004\/jnccn.2011.0072","article-title":"Esophageal and esophagogastric junction cancers","volume":"9","author":"Ajani","year":"2011","journal-title":"J Natl Comp Cancer Network"},{"key":"10.1016\/j.ejca.2015.07.044_b0045","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.athoracsur.2008.11.001","article-title":"Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival","volume":"87","author":"Donahue","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejca.2015.07.044_b0050","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.044_b0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.2001.19.2.305","article-title":"Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma","volume":"19","author":"Urba","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.044_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1442-2050.2008.00901.x","article-title":"Worldwide esophageal cancer collaboration","volume":"22","author":"Rice","year":"2009","journal-title":"Dis Esophag"},{"key":"10.1016\/j.ejca.2015.07.044_b0065","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cncr.20916","article-title":"Post therapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation","volume":"103","author":"Chirieac","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2015.07.044_b0070","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/cncr.21439","article-title":"Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response","volume":"104","author":"Rohatgi","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2015.07.044_b0075","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/cncr.21346","article-title":"Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus","volume":"104","author":"Rohatgi","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2015.07.044_b0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/annonc\/mdf081","article-title":"Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer","volume":"13","author":"Flamen","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2015.07.044_b0085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.sla.0000208430.07050.61","article-title":"Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer","volume":"243","author":"Levine","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2015.07.044_b0090","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.athoracsur.2004.04.046","article-title":"Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer","volume":"78","author":"Swisher","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejca.2015.07.044_b0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1442-2050.2006.00617.x","article-title":"The importance of PET in the diagnosis and response evaluation of esophageal cancer","volume":"19","author":"Ott","year":"2006","journal-title":"Dis Esophag"},{"key":"10.1016\/j.ejca.2015.07.044_b0100","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00259-007-0521-3","article-title":"Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction","volume":"34","author":"Wieder","year":"2007","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ejca.2015.07.044_b0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-0038-1625322","article-title":"FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding","volume":"44","author":"Stahl","year":"2005","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.ejca.2015.07.044_b0110","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1200\/JCO.2005.05.017","article-title":"Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival","volume":"23","author":"Berger","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.044_b0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1200\/JCO.2006.08.0101","article-title":"American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma","volume":"25","author":"Rizk","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.044_b0120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.24056","article-title":"Influence of the baseline FDG positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation cancer","volume":"119","author":"Javeri","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2015.07.044_b0125","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijrobp.2007.03.035","article-title":"Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer","volume":"69","author":"Kelsey","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2015.07.044_b0130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000135515","article-title":"Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I). A comparison of two phase II trials with long-term follow-up","volume":"31","author":"Bader","year":"2008","journal-title":"Onkologie"},{"key":"10.1016\/j.ejca.2015.07.044_b0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1072-7515(01)01177-2","article-title":"Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management","volume":"194","author":"Griffin","year":"2002","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejca.2015.07.044_b0140","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2015.07.044_b0145","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.athoracsur.2006.06.053","article-title":"Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer","volume":"82","author":"Moskovitz","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejca.2015.07.044_b0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1052-3359(25)00361-8","article-title":"Complications of abdominal right-thoracic (Ivor Lewis) esophagectomy","volume":"7","author":"Bains","year":"1997","journal-title":"Chest Surg Clin N Am"},{"key":"10.1016\/j.ejca.2015.07.044_b0155","article-title":"Randomized trial of two nonoperative regimens RTOG 0113","author":"Ajani","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.044_b0160","unstructured":"Zep RC. A SAS macro for estimating power for ROC curves in one-sample and two-sample cases. Proceedings of the 20th SAS Users Group Internation Conference (SUGI). Paper 223; 1995."},{"key":"10.1016\/j.ejca.2015.07.044_b0165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimator from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ejca.2015.07.044_b0170","doi-asserted-by":"crossref","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.ejca.2015.07.044_b0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1442-2050.2007.00732.x","article-title":"Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus","volume":"21","author":"Smithers","year":"2008","journal-title":"Dis Esophag"},{"key":"10.1016\/j.ejca.2015.07.044_b0180","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1002\/cncr.26122","article-title":"Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy","volume":"117","author":"Suzuki","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2015.07.044_b0185","first-page":"45","article-title":"Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET\/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction","volume":"22","author":"Weber","year":"2013","journal-title":"J Gastroint Liver Dis"},{"key":"10.1016\/j.ejca.2015.07.044_b0190","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ijrobp.2012.10.017","article-title":"Spatial-temporal [(1)(8)F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy","volume":"85","author":"Tan","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2015.07.044_b0195","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00259-011-1755-7","article-title":"Cheze-le Rest C. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology","volume":"38","author":"Hatt","year":"2011","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ejca.2015.07.044_b0200","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00259-012-2325-3","article-title":"Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET\/CT imaging in patients with locally advanced oesophageal carcinomas","volume":"40","author":"Cuenca","year":"2013","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ejca.2015.07.044_b0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/SLA.0b013e3181f66596","article-title":"Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer","volume":"253","author":"van Heijl","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2015.07.044_b0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11307-008-0169-9","article-title":"Metabolic tumor width parameters as determined on PET\/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus","volume":"11","author":"Roedl","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.ejca.2015.07.044_b0215","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ijrobp.2011.12.029","article-title":"Post chemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer","volume":"84","author":"Jayachandran","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2015.07.044_b0220","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ejrad.2014.03.031","article-title":"Prognostic significance of novel (1)(8)F-FDG PET\/CT defined tumour variables in patients with oesophageal cancer","volume":"83","author":"Foley","year":"2014","journal-title":"Eur J Radiol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915007509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915007509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:42:43Z","timestamp":1748587363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915007509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":44,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0959804915007509"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.07.044","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}